Population Pharmacokinetic and Pharmacodynamic Analyses of Obexelimab in Healthy Volunteers and in Patients with Rheumatoid Arthritis or IgG4-Related Diseases

被引：0
|
作者：
Wang, Xiaodong [1 ]
Kirk, Rachel [1 ]
Hua, Simon Lowry [1 ]
机构：
[1] Zenas BioPharma, Waltham, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0002
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [21] Population Pharmacokinetic/Pharmacodynamic and Exposure-Response Modeling of Garadacimab in Healthy Volunteers and Patients With Hereditary Angioedema
    Garcia, Ramon
    Cheng, Shen
    Glassman, Fiona
    Sharma, Ankur
    De Miguel-Lillo, Bernardo
    Wiens, Matthew
    Johnston, Curtis
    Lawo, John-Philip
    Pragst, Ingo
    French, Jonathan
    Polhamus, Dan
    Nandy, Partha
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025,
  • [22] Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus
    Herbert Struemper
    Mita Thapar
    David Roth
    Clinical Pharmacokinetics, 2018, 57 : 717 - 728
  • [23] IgG4-Related Disease in a Rheumatoid Arthritis Patient — a Coincidence or Possible Association? A Case Report
    Mallak Zatreh
    Rishi Sharma
    SN Comprehensive Clinical Medicine, 4 (1)
  • [24] CHARACTERIZATION OF THE GROUP OF PATIENTS WITH IGG4-RELATED SYSTEMIC DISEASE IN RUSSIAN POPULATION
    Sedyshev, S.
    Vasilyev, V.
    Kovrigina, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 292 - 292
  • [25] The Onset of IgG4-related Retroperitoneal Fibrosis under Administration of a TNF Inhibitor in a Rheumatoid Arthritis Patient
    Ogawa, Takao
    Tsujimoto, Kohei
    Shimagami, Hiroshi
    Fukuda, Chiaki
    Hirano, Toru
    INTERNAL MEDICINE, 2023, 62 (21) : 3251 - 3254
  • [26] Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseases
    Maleki, Farzaneh
    Clark, Elias
    Banfield, Christopher
    Byon, Wonkyung
    Nicholas, Timothy
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (04): : 551 - 562
  • [27] Roles of TGF-beta and periostin in fibrosclerosis in patients with IgG4-related diseases
    Ohta, Nobuo
    Kurakami, Kazuya
    Ishida, Akihiro
    Furukawa, Takatoshi
    Suzuki, Yusuke
    Aoyagi, Masaru
    Matsubara, Atsushi
    Lzuhara, Kenji
    Kakehata, Seiji
    ACTA OTO-LARYNGOLOGICA, 2013, 133 (12) : 1322 - 1327
  • [28] Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis
    Taneja, Amit
    Desrivot, Julie
    Diderichsen, Paul Matthias
    Blanque, Roland
    Allamasey, Lisa
    Fagard, Liesbeth
    Fieuw, Ann
    Van Der Aar, Ellen
    Namour, Florence
    CLINICAL PHARMACOKINETICS, 2019, 58 (09) : 1175 - 1191
  • [29] Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis
    Amit Taneja
    Julie Desrivot
    Paul Matthias Diderichsen
    Roland Blanqué
    Lisa Allamasey
    Liesbeth Fagard
    Ann Fieuw
    Ellen Van der Aar
    Florence Namour
    Clinical Pharmacokinetics, 2019, 58 : 1175 - 1191
  • [30] Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis
    Ma, Ying
    Lin, Bi-rong
    Lin, Bei
    Hou, Sheng
    Qian, Wei-zhu
    Li, Jing
    Tan, Min
    Ma, Jian
    Li, Bo-hua
    Wang, Hao
    Wen, Ai-dong
    Guo, Ya-jun
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (03) : 364 - 371
12345